{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:39Z","timestamp":1788326559865,"version":"build-2803163510"},"reference-count":17,"publisher":"The Journal of Rheumatology","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,3,4]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting included a lively debate regarding the optimal management of musculoskeletal (MSK) symptoms in patients with psoriasis (PsO) at risk of or with early psoriatic arthritis (PsA). Drs. Fabian Proft and Laura Savage presented comprehensive, evidence-based retrospective arguments from the perspectives of rheumatology and dermatology. Proft advocated for rheumatologists to lead PsA management by highlighting the specialized training that allows rheumatologists to identify inflammatory diseases and use advanced imaging techniques to differentiate PsA from mechanical MSK conditions. In contrast, Savage emphasized the pivotal role of dermatologists, who often serve as the first healthcare providers (HCPs) to encounter emergent PsA in their patients with PsO. Dermatologists are increasingly aware of the importance of early detection and timely intervention, as well as of the new data that support the concept of \u201ctreating to intercept\u201d in patients at risk of transition from PsO to PsA. Both experts highlighted systemic barriers hindering collaborative care and underscored the necessity of patient-centered approaches that effectively address skin and joint manifestations. This article summarizes the insightful debate, reinforcing the importance of a multidisciplinary approach to optimize patient outcomes with PsA.<\/jats:p>","DOI":"10.3899\/jrheum.2025-0237","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:20:20Z","timestamp":1756729220000},"page":"63-65","source":"Crossref","is-referenced-by-count":0,"title":["Managing Musculoskeletal Symptoms in Patients With Psoriasis: Who Should Be in the Driver\u2019s Seat?"],"prefix":"10.3899","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8932-3349","authenticated-orcid":false,"given":"Karen","family":"Briner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-5439","authenticated-orcid":false,"given":"Pamela","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-033X","authenticated-orcid":false,"given":"Fabian","family":"Proft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-6519","authenticated-orcid":false,"given":"Laura J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"2026090121551305000_52.Suppl_3.63.1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.clinthera.2023.05.010","article-title":"Pharmacologic treatment strategies in psoriatic arthritis","volume":"45","author":"Ayan","year":"2023","journal-title":"Clin Ther"},{"key":"2026090121551305000_52.Suppl_3.63.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04775-2"},{"key":"2026090121551305000_52.Suppl_3.63.3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/oxfordjournals.qjmed.a068085","article-title":"Psoriatic arthritis (PSA)\u2014an analysis of 220 patients","volume":"62","author":"Gladman","year":"1987","journal-title":"Q J Med"},{"key":"2026090121551305000_52.Suppl_3.63.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204858"},{"key":"2026090121551305000_52.Suppl_3.63.5","first-page":"593","article-title":"Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement","volume":"37","author":"Zuliani","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026090121551305000_52.Suppl_3.63.6","first-page":"469","article-title":"Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the psoriasis epidemiology screening tool (PEST) questionnaire","volume":"27","author":"Ibrahim","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2026090121551305000_52.Suppl_3.63.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.089441"},{"key":"2026090121551305000_52.Suppl_3.63.8","unstructured":"British Society for Rheumatology . Rheumatology workforce: a crisis in numbers. Workforce Policy Report 2021. [Internet. Accessed March 14, 2025.] Available from: https:\/\/www.rheumatology.org.uk\/Portals\/0\/Documents\/Policy\/Reports\/BSR-workforce-report-crisis-numbers.pdf"},{"key":"2026090121551305000_52.Suppl_3.63.9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026090121551305000_52.Suppl_3.63.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220865"},{"key":"2026090121551305000_52.Suppl_3.63.11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.41946","article-title":"Incidence of psoriatic arthritis among patients receiving biologic treatments for psoriasis: a nested case-control study","volume":"74","author":"Rosenthal","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026090121551305000_52.Suppl_3.63.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080691"},{"key":"2026090121551305000_52.Suppl_3.63.13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026090121551305000_52.Suppl_3.63.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222562"},{"key":"2026090121551305000_52.Suppl_3.63.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"2026090121551305000_52.Suppl_3.63.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531"},{"key":"2026090121551305000_52.Suppl_3.63.17","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/msc.1690","article-title":"The role of the multidisciplinary team in the management of psoriatic arthritis","volume":"20","author":"Jadon","year":"2022","journal-title":"Musculoskelet Care"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:55:26Z","timestamp":1788324926000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":17,"journal-issue":{"issue":"Suppl 3","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.3899\/jrheum.2025-0237"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0237","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}